EcoCRM® (CRM197)

Research and cGMP grade

FinaBio can support your conjugate vaccine program

We are experts in conjugate vaccine development and manufacture,
not just a platform expression company.

FREE SAMPLE CRM197ORDER CRM197
SCALABILITY

Same manufacturing process for research and clinical grade facilitates  development and scale-up

PROVEN TRACK RECORD

EcoCRM® is the carrier protein for multiple vaccines in Phase I and II clinical trials

EASY FILING

US FDA Drug Master File Regulatory Support File for non-US

LEARN MOREOTHER CARRIER PROTEINS
We began working with Fina Biosolutions since learning of their efforts to make CRM197 more affordable. FinaBio’s pricing allowed us to switch from using KLH to their EcoCRM® (CRM197) as the carrier protein for our substance use disorder vaccines. EcoCRM® has performed very well in our preclinical studies and we are preparing for our phase 1 clinical trial. In addition to providing an excellent product, FinaBio has been responsive to our needs, providing support & expertise at every stage of the journey in developing our conjugate vaccine.
- Dr. Marco Pravetoni
University of Washington, Seattle
FinaBio’s ready-to-conjugate CRM-maleimide is extremely convenient to use. We have used it to create more than forty different conjugates for a conjugate vaccine project and couldn’t be happier with the results.
- Craig McElroy, PhD.
College of Pharmacy, OSU